Article Listing - Abbott's Humira gains FDA panel backing for wider use

FURTHER WELLCOME SHARE SELL-OFF

9 March 1992

Six years after the first share floatation in UK drugmaker Wellcome, the Wellcome Trust has revealed that a further tranche...

INNOTHERA SEEKING DEVELOPMENT CASH

9 March 1992

The French drug manufacturer, Innothera, which specializes in products for women's diseases, says it is ready to open its capital...

WARNING LETTER TO MILES ON NIMOTOP

9 March 1992

Promotion of the neurone-specific calcium channel blocker Nimotop (nimodipine) in the USA by Miles Laboratories for the unapproved indication of...

BULLETIN REVIEWS NEW TOPICAL PRODUCTS

9 March 1992

Leo Laboratories' Dovonex (calcipotriol) represents an interesting and useful addition to the menu of treatments available for chronic plaque psoriasis,...

MEDEVA'S NEW CORACTEN FORM

9 March 1992

Medeva plc and its subsidiary Evans Medical have launched in the UK a new product in the Coracten (nifedipine) range....

UK DTP VACCINATION SCHEDULE

9 March 1992

New findings released by a team of UK clinicians, under the direction of Robert Booy of the Radcliffe Hospital, Oxford,...

US APPROVAL FOR CARDENE SR

9 March 1992

Syntex Corp has received approval from the US Food and Drug Administration to market its Cardene SR, a slow-release formulation...

MMD'S 5HT3 RECEPTOR ANTAGONIST

9 March 1992

The pharmacokinetic properties of a new anti-emetic 5-HT3 receptor antagonist from Marion Merrell Dow, MDL 73,147EF, will be described at...

RISING HEALTH CARE COSTS IN SPAIN

17 February 1992

Family expenditure in Spain on medication has progressively fallen in recent years, and at the same time, the costs of...

AIDS TREATMENT FROM JOHNSON MATTHEY

17 February 1992

A new potential treatment for AIDS patients has been developed by the precious metals group of UK-based Johnson Matthey. As...

Showing 94721-94730 of 95316 articles